This research was planned to assess the protective effect
Introduction
Diabetes mellitus (DM) is one of the major intimidations to health in the world. It was expected to be more prevalent in 2025 (1) . Hyperglycemia is associated with vascular complications and kidney diseases (2) . There are several other factors that play a great role in diabetes for instance, obesity and oxidative stress which lead to more ferocious complications (3) , with decreased humoral immunity (4) . DM type 1 is a consequence of the annihilation of β-cells of the pancreas (5) . Deficiency of insulin primes to hyperglycemia. STZ is a structural analog of glucose (Glu) and N-acetyl glucosamine is reserved up by β-cells via the GLUT 2 transporter subsequently lead to β-cell loss via DNA destruction (6, 7) . Moreover, cells that express GLUT 2 transporter like liver and kidney cells are also vulnerable to STZ. This clarifies kidney and liver complications (8, 9) . Oxidative anxiety is an inequity among the reactive oxygen species (ROS) and antioxidant protection of the body, which play a great role in diabetic complications (10). Since many studies stated that oxidative anxiety, facilitated by diabetes-induced production of ROS, lead to progress of diabetes, it noticed that improving oxidative anxiety via antioxidants might be a successful approach for demoting diabetic complications (11, 12) .
Green tea (Camellia sinensis) is prevalent nutraceutical antioxidant especially in Asian countries (13) . Green tea has an important role in decreasing blood pressure, low-density lipoprotein cholesterol, and oxidative stress (14). Many studies proved the valuable effects of green tea on diabetic complications (15, 16) as well as it has antihyperglycemic effect in STZ diabetic animals (17) . Moreover, green tea shows antioxidants and free radicals scavenger properties (18) .
This study was done to evaluate the protecting pathway by which green tea alleviate streptozotocin-induced diabetes in mice.
Material and methods

Chemicals
We utilized a pharmaceutical-grade of STZ from Sigma (St. Louis, MO, USA). The STZ solution prepared by dissolving STZ in citrate buffer (0.01 M, pH 4.5) (19, 20) . Chemicals consumed were of analytical grade. Total cholesterol, high-density lipoprotein (HDL)-cholesterol and triglyceride (TG) standard kits were purchased from Erba Diagnostics Mannheim Gambh, Germany.
Green tea extract
The green tea tablets, each tablet contain green tea extract 200 mg manufactured by El Obour City pharmaceutical industries. Following grinding, the obtained green tea powder dissolved in distilled water. This solution was provided to mice orally by using a stomach tube. (21) 
Experimental animals
Seventy-five female albino mice, (9 -11 weeks old, weighing about 25-30 gm was used.
They obtained from Medical Technology Center, University of Alexandria, Egypt. Animals were managed according to the rules and regulations of our university committee. Female albino mice were housed in stainless steel pens of ambient temperature 23±2°C and light (12 h light/12 h dark) and free access to food and water. The mice were fed a standard diet according to (22) .
Initiation of experimental diabetes
After 2 weeks of accommodation, the mice were exposed to a 12 h fast. The mice were I/P injected with a single dose of 200 mg/kg STZ (7, 19) . STZ was freshly dissolved in 0,1M cold sodium citrate buffer, pH 4.5 (19, 20) .after 2h from injecting we put 5% glucose and food to injected mice to avoid death (20) .we replace 5%glucose with water after 2h.The urine glucose level was checked three days after STZ injection to check the progress of diabetes. The diabetic mice were steadied for 5 days and then the experiment beginning. Mice which showed glucose levels >250 mg/dL was considered diabetic.
Experimental design
After acclimatization, mice were alienated randomly into five groups of 15 mice each: Group 1: healthy control mice received distilled water Group 2 (diabetic group): will be used as control diabetic mice. The mice were injected I/P with one dose of 200 mg/kg STZ (7, 19) . In group 3 (treated group with green tea) diabetic mice were administrated green tea at a dose of 200 mg/kg bw orally by stomach tube daily for 21 days. In group4 (protective group with green tea) mice were given green tea at dose of 200 mg/kg by stomach gavage for 21 days and then diabetes was induced with a single dose of 200 mg/kg streptozotocin with continuous treatment with green tea at dose of 200 mg/kg orally for 21days. In group 5 (control green tea group) non-diabetic mice received green tea (200 mg/Kg /day)dissolved in distilled water orally by stomach tube for 21 days according to (23).
Sampling
Mice were sacrificed by cervical decapitation. Body weights of all the animals were recorded prior to the treatment and sacrifice. Weight change % = Initial weight -Final weight × 100/Initial weight Blood samples were collected in either EDTA coated tubes for the hematological investigation or plain tubes for serum separation (24) for biochemical assays. Kidneys, liver, spleen, and pancreases after decapitation were quickly removed and washed by cold saline to remove extraneous materials. Each organ was divided into 3 specimens. The first was snap frozen with liquid N2 and kept at -80°C until use for RNA extraction. The second was fixed in 10% neutral buffered formalin for the histological examination. The third was used for transmission electron microscopy (TEM) handled using standard techniques.
Blood analysis
The serum samples for measurement of blood glucose level was determined based on glucose oxidase method (25) , insulin concentrations were determined according to (26) using an insulin-ELISA kit (Morinaga Seikagaku, Tokyo, Japan). Malondialdehyde (MDA) was quantified by the method of Ohakawa et al. (27), HbA1c was appraised using DCA 2000 analyzer (Bayer, Elkhart, IN) (28, 29) . Total protein concentration in serum was assayed colorimetrically using commercial kit (Diamond, Egypt) and according to Lowry et al. (1951) . Serum levels of total cholesterol, triglycerides, and high-density lipoproteins cholesterol (HDL-C) were estimated by quantitative colorimetric assay (Stanbio Laboratory, Inc., Texas, USA) according to (30) and low-density lipoprotein cholesterol (LDL-C) concentration assessed according to the formula of Friedewald et al; (31) . LH, FSH, and estrogen were assessed using IMMULITE chemiluminescent assay kits (DPC, Glyn Rhonwy, Llanberis, Gwynedd, UK) (32) . The Horiba ABX 80 Diagnostics (ABX pentra Montpellier, France) was used for hematological examination (33) .
Histopathological and transmission electron microscope examination
The histopathology was carried out according to (34) using hematoxylin and eosin staining technique. Preparation od samples for transmission electron microscope (TEM) using collagen-coated nickel grids was applied as previously described (35).
Molecular investigation
Total RNA was extracted from tissue samples using RNA extraction kit (easy-REDTM, iNtRON Biotechnology, #17063, South Korea). cDNA synthesis was performed using reverse transcription kits (Thermo Scientific, Fermentas, #EP0451) which include the following: Revert Aid H Minus Reverse Transcriptase enzyme, Oligo dT,5X Reaction Buffer, RiboLock RNase Inhibitor, and dNTP Mix. Concentration of RNA and cDNA quantify using a Nanodrop (Q5000 Uv-Vis spectrophotometer, USA).
Real-time PCR with SYBR Green (2X Maxima SYBR Green/ROX qPCR Master Mix) used to determine the expression of the target genes in the liver, with GAPDH as a housekeeping gene, according to the manufacturer protocol (Thermo Scientific, USA, # K0221). The primers used in the amplification are shown in Table 1 . The web-based tool, Primer 3 (http://www-genome.wi.mit.edu/cgibin/primer/primer3_www.cgi) used to design these primers. To confirm primer sequence is unique for the template sequence; we check similarity to other known sequences with BLAST. Calculation of fold changes in gene expression was done using2 −ΔΔCt method.
Statistical analysis
Data was analyzed using GraphPad Prism 5 (GraphPad Software, San Diego, CA, USA). Results subjected to Tukey's multiple comparisons post-hoc test. Values are statistically significant when p < 0.05.
Results
Growth weight and Biochemical analysis
Diabetic mice had a significant drop in body weight in relation to other groups.as shown in figure 1 .The diabetic mice showed a significantly increased level of serum glucose, triglycerides, cholesterol, LDL-C, VLDL-C relative to the control group and other treated groups and green tea protective groups. Serum insulin, total protein and HDL-C statistically decreased in diabetic mice as compared to the control group, treated and green tea protective groups (Table  2) . Serum HbA1C pointedly increased in diabetic mice relative to the control group (Table  2) . Diabetic mice showed a noteworthy increase in MDA compared to their equivalent levels in control animals. However, treated groups with green tea showed a significant diminution in the levels of MDA in relation to diabetic mice. Protective groups treated with green tea exhibited a significant reduced MDA levels as compared to diabetic mice (Table 2) . LH, FSH and estrogen levels did not show any significant difference among all groups (Table 3) .
Hematological analysis
RBC and WBC count, PCV, neutrophil % and platelets levels in diabetic mice decreased significantly, while MCV, MCH, and MCHC increased significantly in diabetic mice compared to the control mice. Green tea extract significantly normalized RBC and WBC count, PCV, neutrophil % and platelets in diabetic mice as well as MCV, MCH, and MCHC of diabetic mice to the control level (Table 4) .
Histopathological studies
All results of histopathology were displayed in figure 
Outcome of streptozotocin, green tea on the relative expression of TGFβ1gene and TNFα gene
The results of qPCR were presented in Figure 4 . A considerable upregulation in the expression of TGFβ1 gene in liver was found following administration of Streptozotocin as compared to the control group and other treated groups. Green tea treated diabetic mice showed a noteworthy decrease TGFβ1 gene expression as compared to the diabetic group. Furthermore, pre-treatment by green tea led to a significant decrease in TGFβ1 expression. Green tea alone led to insignificant downregulation of TGFβ1 gene expression as compared to the control group. TNFα upregulation was found following administration of Streptozotocin as matched to normal one and other treated groups. Administration of green tea with Streptozotocin resulted in a significant decrease in TNFα gene expression as compared to diabetic one. Furthermore, pre-treatment by green tea led to a significant reduction of TNFα expression. Administration of green tea alone led to momentous decreased of TNFα gene expression in relation to control group. 
Discussion
Diabetes is a metabolic ailment characterized by hyperglycemia. Its consequences from faults in insulin creation and this leads to disturbance in the metabolism followed by worsening of muscles which leads diabetic complications (36).
Our result revealed that diabetic mice had a significant drop in body weight as shown in figure 1. This result was consistent with (37-39) who reported momentous reduction in body weight in diabetic mice and attributed this effect to the highly muscle wasting and damage of tissue proteins.
Diabetic mice have a marked rise in the levels of serum glucose, triglycerides, cholesterol, LDL-C, VLDL-C when compared with control groups. The obtained data were parallel to that reported by (40) who found that diabetes induces substantial surges in the levels of these parameters and attributed this effect to insulin deficiency that hinder lipoprotein lipase triggering hypertriglyceridemia.
On the other hand, serum levels of insulin, total protein and HDL-C statistically decreased in STZ mice as compared to the control groups and these results agreed with (41-43) who reported similar reduction in these parameters in diabetic animals. Serum total protein in diabetic animals is obviously related to loss of structural proteins and drop in body weight which induced as a result of deficiency of insulin in diabetic mice.
Result revealed that, green tea extract in diabetic mice resulted in noteworthy regaining in body weight, decreases serum glucose in diabetic one, decrease cholesterol, triglyceride, and LDL-C levels, and improved serum total protein and HDL-C. In parallel, (44) also reported that administration of green tea extract in diabetic mice resulted in similar improvement and attributed them to the antihyperglycemic and hypolipidemic activity of green tea (45) . Moreover, daily administration of green tea to diabetic mice decreased glucose levels and HbA1c levels and this result was an in consistence with (47).
In the present study, diabetic mice showed a noteworthy rise in MDA relative to control animals. However, pre and post-treatment of diabetic animals with green tea lead to a marked decrease in MDA level. These results was compatible with that obtained by (46) who reported that increase in MDA can be the result of diabetic complications.
MCV, MCH, and MCHC markedly increased in diabetic mice as compared to control mice and suggesting occurrence of anemia in diabetic mice. This result agreed with (50) who reported that anemia in diabetes was due to the increased non-enzymatic glycosylation of RBC membrane proteins, which associated with hyperglycemic oxidation of this glycosylated membrane. In contrast, green tea normalized the elevated MCV, MCH, and MCHC of diabetic mice. These results were consistent with those obtained by (50) who attributed this effect to the decreased lipid peroxide in RBC membrane which decreases hemolysis. The disrupted body defense mechanism of the diabetic animal against infections was distressed due to the neutrophil role in diabetes (48) . The obtained results were similar to those obtained by (49) who reported that diabetic mice had a decreased WBC count and attributed this to Streptozotocin ability to suppress the immune system through hindrance of leukocytosis in the bone marrow. We also found a decrease in platelets levels in diabetic mice. In parallel, (51) also reported that platelet accumulation ability in diabetic mice could be due to deficiency of insulin. In contrast, green tea can return this reduced level to a level comparable to that of the control animals. These results are consistent with (52) who reported this effect to green tea ability to increase the biosynthesis of clotting factors. Similar to results obtained by (53), we found no significant change in LH, FSH and estrogen levels among the groups.
Green tea treatment led to a significant down-regulation of TGFβ1 gene expression in liver. These results agreed with (54) who stated that green tea decreased hepatic expression of TGFβ1 and this accountable for reduction collagen synthesis and decrease fibrosis. Administration of green tea also led to significant downregulation of TNFα gene expression. In inconsistence, (55) established that green tea persuaded growth inhibition and apoptosis by decrease TNFα expression. TNFα expression may also have a valuable effect on diabetes since TNFα is intricate in developing diabetes.
Histopathological study and transmission electron microscope study revealed that administration of green tea can normalize the liver, kidney, pancreas and spleen that were deteriorated by STZ. In consistence, (56) reported that polyphenols (main ingredients in green tea) have anti-diabetic effects (57).
Conclusion
From the data found in this study, we can conclude that green tea has antidiabetic action though down-regulation of TGFβ1 and TNFα gene expression in liver, improvement of lipid metabolism and body weight in streptozotocininduced diabetic mice. This study verified the protective action of green tea on experimentally induced diabetic mice.
